Super Bowl to Be Streamed Live For Free By Fox

Fox playoff games wont get the same treatment

Jan 10 2014, 9:10am CST | by Shane McGlaun

2 Updates

YouTube Videos Tweets Comments

Football fans that won't be near a TV when the Super Bowl airs have something to be thankful for. Fox has announced that it will live stream the Super Bowl for free on the web reports Variety. That means you will be able to watch the big game from anywhere you can get a web connection and power for your computer.

The Super Bowl will be live streamed on February 2 and the 2014 game will mark the third year it has been streamed for free. Oddly, while Fox is letting anyone watch the Super Bowl for free, it is hiding certain post season games in the playoffs behind a pay wall.

Some of the post season games will only be available on the web to people that subscribe to cable TV companies that are participating. Some of those participating cable providers include Comcast. AT&T U-verse, and Cablevision Systems. The streaming coverage of the game will begin at 6:30 pm Eastern on Sunday February 2.

Football fans will be able to see streaming coverage of the AFC playoffs on CBSsports.com at no cost. CBS will be offering key playoff games free online for the first time ever.

See the original post here:

Super Bowl to Be Streamed Live For Free By Fox

Stem Cell Treatment for Arthritis

Stem Cell Treatment for Arthritis

Mesenchymal stem cells have been shown in recent studies to have significant effects on a variety of conditions including both rheumatoid arthritis and osteoarthritis. As the mechanisms behind these two forms of arthritic degeneration differ, the potential stem cell treatment for arthritis is likely to be administered differently and make use of a variety of properties of stem cells, such as their regenerative abilities, and the capacity for some stem cell types to help regulate immune function. Patients undergoing stem cell treatments for unrelated conditions have reported significant relief from their arthritis after such therapy even though this was not the reason for them obtaining treatment initially; these stories are anecdotal however, and do not constitute evidence for applying treatment more widely. Intravenous stem cell therapy using haematopoietic stem cells has been used extensively in veterinary medicine for a number of years. Often, stem cell treatment for arthritis in companion animals and race horses with signs of the condition (both rheumatoid and osteoarthritis) direct injections of stem cells into the damaged joint have proven effective at inhibiting the autoimmune attacks consistent with RA, reducing inflammation and pain in the joint, and supporting active tissue regeneration.

Stem Cell Treatment for Arthritis brings hope to millions suffering from arthritic conditions

The conditions under which stem cells are implanted appear to make all the difference between active regeneration and hypertrophy of joint tissue. Researchers are wary of the ad hoc use of stem cells for joint repair as it may be that the growth encouraged by stem cells may be adversely influenced by pre-existing pathology in an arthritis patients joints leading to exaggerated tissue growth that may further exacerbate the problems. Using a small number of chondrocytes alongside mesenchymal stem cells may make a significant difference in cultivating healthy cartilage repair without hypertrophy (excessive growth) occurring (Aung, et al, 2011).

A further study by Abedi (et al, 2010) appears to show that the use of scaffolding material alongside mesenchymal stem cell administration improves the healing process in induced articular cartilage defects in animal models (rabbits) in comparison to the stem cells alone. By encouraging differentiation into cartilage tissue types the almost universal progression of articular cartilage damage to osteoarthritis could, theoretically, be prevented using stem cell therapy. MSCs from osteoarthritis patients used in research has also led to the development of intelligent surfaces which can effectively prevent hypertrophy of such stem cells in the laboratory whilst facilitating cartilage regrowth (Petit, et al, 2011); further research in vitro is required to assess their use for therapeutic purposes however. A review of current research into synoviocytes and chondrogenesis has also highlighted a potential source of stem cells which may actively aid repair of avascular meniscal injuries that are otherwise unresponsive to treatment and commonly lead to osteoarthritis (Fox, et al, 2011).

Mesenchymal stem cells, which can differentiate into bone, cartilage, and a number of other cell types appear to hold great potential for easing osteoarthritis joint pain and possibly regenerating damaged tissue. However, MSC therapy alone is unlikely to address the systemic issue of autoimmune rheumatoid arthritis. Just as haematopoietic stem cells can help combat leukaemia, their use following myeloablation (the destruction of the bodys immune-forming cells in the bone marrow) looks promising for treatment of RA (Sykes, et al, 2005).

A study by Bhattacharya (et al, 2001) to test the safety of using umbilical cord blood for those with a variety of conditions found that the transfusions were well tolerated by all 62 of the patients and that the cord blood had the advantages of a higher oxygen carrying capacity, many growth factors and cytokines, and was also less likely to cause an immune reaction than adult whole blood transfusions. The study did not aim to assess the potential benefits of the stem cell treatment, only the safety of such procedures for those with rheumatoid arthritis, arthritis in the neck, ankylosing spondylitis, and systemic lupus erythematosus, amongst other conditions.

The ability to derive stem cells from patients themselves is also opening up a whole new realm of possible treatments which do not require the use of human embryonic stem cells or cord blood stem cells which are less readily available and mired in some ethical controversy. Autologous stem cell transplants are also advantageous as they do not trigger an immune response causing rejection of the material in the body; immunosuppressant drugs are, therefore, not necessary. Jorgensen (et al, 2004) stated that mesenchymal stem cells appeared to be good candidates for the regeneration of arthritic tissue and that more research was required to assess their viability. This research has been carried out in subsequent years by a whole host of scientists such as Mao (2005), Gonzlez (et al, 2009), and Tyndall (et al, 2010).

Some studies have looked at animal models with induced rheumatoid arthritis and their reaction to mesenchymal stem cell transplantation. Across a number of studies the effects have been positive, with the Th1-induced autoimmune response down-regulated by the stem cell treatment. Human adipose-derived mesenchymal stem cells also decreased inflammatory cytokines and chemokines in the mouse models and actively increased the production of antiinflammatory substance interleukin-10 in lymph nodes and joints. A, perhaps unexpected, benefit of human AD-MSCs was the de novo generation of antigen-specific CD4+CD25+FoxP3+ Treg cells, which were then able to suppress those immune system cells which react against the bodys own tissue.

According to Passweg and Tyndall (2007), more than a 1000 patients with autoimmune diseases have been treated with haematopoietic stem cells between 1996 and 2007. Most of these patients had Multiple Sclerosis, systemic lupus erythematosus, RA, or systemic sclerosis and many of those treated have enjoyed long-term disease-free remissions and immune reconstitution since treatment. Unfortunately, there remains a risk of treatment related mortality with such stem cell therapy as it relies on the destruction initially of the patients immune system in order to reset it with the infused stem cells and remove the autoimmune components. This temporarily opens the patients up to increased risks of infection which can be fatal. Improvements in patient care during the treatments have reduced this risk substantially, but it is still a major consideration, particularly for those otherwise doing well on conventional medications. Tyndall and Laar (2010) found that incomplete, low immunoablative intensity, early conditioning was related to patient relapse. This is most likely due to residual lesional effector cells; the patients faulty immune system effectively repopulated itself with self-reactive immune cells when only partially destroyed by initial myeloablative treatment.

Here is the original post:

Stem Cell Treatment for Arthritis

Stem Cell Therapy for Arthritis and Injuries | Regenexx Procedures

The Regenexx Procedures are a family of non-surgical stem cell and blood platelet treatments for common injuries and degenerative joint conditions, such as osteoarthritis and avascular necrosis. These stem cell procedures utilize a patients own stem cells or blood platelets to help heal damaged tissues, tendons, ligaments, cartilage, spinal disc, or bone.

Regenexx Stem Cell and Blood Platelet Procedures offer a viable alternative for individuals who are suffering from joint pain, or who may be considering elective surgery or joint replacement due to injury or arthritis. Patients avoid the lengthy periods of downtime, and painful rehabilitation that typically follow invasive surgeries.

The list below represents the most commonly treated conditions using Regenexx stem cell or platelet procedures. It is not a complete list, so please contact us or complete the Regenexx Candidate Form if you have questions about whether you or your condition can be treated with these non-surgical procedures. The type of procedure used (stem cell or blood platelet) to treat these conditions is largely dependent upon the severity of the injury or condition.

The Centeno-Schultz Clinic is theoriginalstem cell based musculoskeletal practice in the U.S., with more stem cell orthopedics experience than any other clinic. We are also physician leaders in stem cell treatments for arthritis and injuries in terms of research presentations, publications, and academic achievements.

The episode features Dr. Centeno and Dr. Hanson, along with patient Barbee James, who required stem cell treatment after a failed micro fracture and continued problems following traditional knee surgery. The episode provided a nice overview of a Regenexx-SD (same-day) stem cell procedure for Barbees knee cartilage damage.

On February 28, 2013 Seattle King TV featured Regenexx patient Paul Lyon, who underwent a Regenexx-SD knee procedure in our Broomfield clinic. The story looks at his results and includes an interview with Dr. Christopher Centeno, along with footage in our advanced lab where stem cells are processed as part of the procedure.

Regenexx Network Physician Dr. Mayo Friedlis (Washington D.C. area) is featured in this recent news story about stem cell therapy, which explores the Regenexx-SD stem cell procedure and a very active seniors outcome following his knee stem cell injection.

Our Pittsburgh, PA. Regenexx Network Provider, Rehabilitation and Pain Specialists, was recently featured in a news story about treating a patients knee pain with stem cells. The patient returned to their clinic for this procedure after experiencing success with the stem cell treatment he received on his other knee.

Read more here:

Stem Cell Therapy for Arthritis and Injuries | Regenexx Procedures

Learn about stem cell therapy and application at Vail event

VAIL The Vail Symposium hosts Dr. Scott Brandt, Dr. Kristin Comella and Dr. Stan Jones who will lead an interactive discussion on the history, evolution, practical applications and clinical results around stem cell treatments Friday evening in Vail.

The program is part of the Symposiums ongoing Living at Your Peak series, which is dedicated to exploring new breakthroughs in medicine and helping people live healthier, more active lives.

This program fits perfectly with our Living at Your Peak series, said Tracey Flower, the Symposiums executive director. There is a lot surrounding this topic, and has been for quite some time. With recent research in a changing medical industry, it is a great topic to discuss.

An example of breakthroughs in stem cell therapy comes in the form of the record-shattering Broncos quarterback, Peyton Manning. After failed surgeries, Manning traveled to Germany to undergo stem cell treatment on his cervical spine. At 37, Manning is playing his best football.

During this educational program, panelists will discuss the evolution of the stem cell field, explain current procedures, present research and clinical findings, and talk about the potential for stem cell applications in the future.

Join the Vail Symposium at 5 p.m. Friday at the Antlers Hotel in Vail for this event, titled: Stem Cells: The Future of Medicine is Now. Space is limited; reserve your tickets at http://www.vailsymposium.org/calendar or call the Vail Symposium at 970-476-0954.

More about the panelists

Dr. Scott Brandt: Brandt, the medical director of ThriveMD in Edwards, specializes in regenerative and restorative medicine. Brandt completed his undergraduate studies at the University of Michigan at Ann Arbor, and attended medical school at Bowman Gray School of Medicine, Wake Forest University in North Carolina. He then completed his anesthesiology residency training and internship at the University of Illinois and Michael Reese Hospitals in Chicago. As a resident in anesthesiology, Brandt specialized in interventional pain management. Since 1997, this focus has kept him on the leading edge of medical innovations that provide longer lasting solutions for acute and chronic pain. The advancement of stem cell therapy, coupled with Brandts expertise in image-guided injections, has made joint rejuvenation an important part of his practice.

Dr. Kristin Comella: In 2013, Comella was named as one of the 25 most influential people in the stem cell field. She has more than 14 years of experience in regenerative medicine, training and education, research, product development and has served in a number of senior management positions with stem cell related companies. Comella has more than 12 years of cell culturing experience including building and managing the stem cell laboratory at Tulane Universitys Center for Gene Therapy. She has also developed stem cell therapies for osteoarthritis at Osiris Therapeutics. Comella has been a member of the Bioheart senior management team since 2004 and is currently serving as its chief scientific officer.

Dr. Stan Jones: Widely known for performing a ground-breaking stem cell infusion on Governor Rick Perry during a spinal surgery in 2011, Jones is a surgeon and stem cell expert. He received his bachelors degree from Texas Tech in Lubbock before earning his medical degree from the University of Texas Southwestern Medical School in Dallas. Jones continued his medical training at the University of Utah Medical School in Salt Lake City and a residency at the University of Texas Medical School at Houston. Jones was awarded a fellowship to study the lower back at Wellseley Hospital in Toronto, Canada. In addition, he served in the U.S. Army Medical Corp as a Captain. He is licensed to practice in the state of Texas and is certified by the American Board of Orthopedic Surgery.

Continue reading here:

Learn about stem cell therapy and application at Vail event

Researchers study stem-cell therapy for feline kidney disease

Jan 09, 2014 by Jennifer Dimas

Chronic kidney disease in older cats is the focus of a fifth clinical trial under way at Colorado State University's James L. Voss Veterinary Teaching Hospital, where veterinarians are exploring novel stem-cell therapy that could, for the first time, hold promise for treating one of the most perplexing feline diseases.

CSU researchers seek area cats with the disease to participate in the clinical trial; cats with concurrent diseases are not eligible. For information about the trial and to determine eligibility for enrollment, visit col.st/1lB4KHf .

Studies suggest that about 50 percent of cats older than 10 suffer from chronic kidney disease.

Although the disease is very common, risk factors are poorly understood and it is tough to treat: Chronic kidney disease is considered irreversible, and treatment typically centers on slowing progression of the disease through supportive care, such as dietary changes, injected fluids and blood-pressure medication.

Yet in a pilot study last year, CSU veterinarians determined that stem-cell therapy could provide a new treatment option for cats. After preliminary results, the research team is further investigating the ability of stem cells to repair damaged kidneys.

Veterinarians are intrigued by use of stem-cell therapy for chronic kidney failure in cats because earlier studies demonstrated that the approach could decrease inflammation, promote regeneration of damaged cells, slow loss of protein through urine and improve kidney function, said Dr. Jessica Quimby, a veterinarian leading the CSU research.

"In our pilot study last year, in which stem cells were injected intravenously, we found stem-cell therapy to be safe, and we saw evidence of improvement among some of the cats enrolled in the trial," Quimby said. "In this study, we will further explore stem-cell therapy with the new approach of injecting the cells close to the damaged organs. We hope this proximity could yield even better results."

For the CSU study, the stem cells used have been cultivated from the fat of young, healthy cats; donor animals are not harmed.

The study will track cats with chronic kidney disease for about two months, with a variety of diagnostic tests conducted before and after stem-cell treatment to analyze kidney function.

See the original post here:

Researchers study stem-cell therapy for feline kidney disease

Documenting Faith in Prison

January 10, 2014|8:42 am

New York based photographer Serge J-F. Levy, visited six maximum security prisons across the country between 2002 and 2003 to photograph inmates embrace spirituality in a series of images called, "Religion in Prison."

The project was sparked by Levy's own curiosity and what he found through each interaction with those incarcerated who are Christian, Jewish, Wiccan, Muslim and Buddhist, and how religion brings out their softer side, despite their labels as criminals.

"There's this sincere desire on the part of many inmates to try to understand the state of their soul," Levy said, according to Slate.com. "They're trying to understand their predicament, and I think that spirituality in prison not so infrequently dovetails with a form of analysis or therapy. I think there's a sense of introspection and evaluation of one's life that happens within these religious environments."

Read more at http://www.christianpost.com/news/ny-based-photographer-enters-6-maximum-security-prisons-to-capture-inmates-embracing-their-religion-112110/

Carrie Underwood Praising God With 'How Great Thou Art' Will Leave You in Tears (VIDEO)

Spreading God's Glory Online

Read the original post:

Documenting Faith in Prison

Cygnus headed to space station with food, clothing, and other supplies

After a series of delays, including a 24-hour slip prompted by a solar flare,Orbital Science's robotic Cygnus spacecraft is en route to the International Space Station.

The commercial spaceflight company Orbital Sciences Corp. launched a robotic spacecraft from Virginia's Eastern Shore Thursday (Jan. 9) on a milestone flight: the company's first official cargo delivery to the International Space Station.

Subscribe Today to the Monitor

Click Here for your FREE 30 DAYS of The Christian Science Monitor Weekly Digital Edition

An Orbital-built Cygnus spacecraft launched into space atop the company's Antares rocket from a seaside pad at NASA's Wallops Flight Facility on Wallops Island, Va. Liftoff occurred at 1:07 p.m. EST (1807 GMT) after a series of delays, including a 24-hour slip due to ahuge solar flare on Tuesday.

The Cygnus spacecraft is hauling about 2,780 lbs. (1,260 kilograms) of fresh food, clothing, scientific equipment and other gear for astronauts on the International Space Station. The mission, called Orb-1, is the first of at least eight cargo missions Orbital will fly for NASA under a $1.9 billion contract. [See more launch photos of Orbital's 1st Cygnus cargo mission]

"We are really looking forward to thisfirst Orbital cargo mission," Dan Hartman, NASA's deputy space station program manager, said in a prelaunch briefing this week.

The Cygnus spacecraft is due to arrive at the space station early Sunday (Jan. 12), where it will be captured by astronauts using a robotic arm and attached to a station docking port.

Orbital'sCygnus spacecraftare bus-size cylindrical vehicles designed to haul payloads of up to 4,400 lbs. (2,000 kg) to the International Space Station. They include an Orbital-built service module for power and propulsion and a 17-foot-long (5 meters) pressurized compartment built by Italy's Thales Alenia Space.

In April 2013, Orbital launched itsfirst Antares rocket test flightfrom Pad-0A at NASA's Wallops Flight Facility. A second demonstration flight in September launched the first Cygnus vehicle to the space station. Pad-0A at Wallops is managed by Virginia's commercial Mid-Atlantic Regional Spaceport.

Go here to see the original:

Cygnus headed to space station with food, clothing, and other supplies

Space Radiation Can Affect Rocket Launches

On Jan. 8, 2014, Orbital Sciences Corp. elected to scrub that day's launch attempt of an Antares rocket from NASA's Wallops Flight Facility, Wallops Island, Va., due to unusually high levels of space radiation - an example of the ways in which space weather can affect human technology.

Monitoring for space radiation - which refers to excessive high-energy protons in near-Earth space, often funneled in from space in association with an event on the sun such as the solar flares and associated coronal mass ejections that occurred on Jan. 7, 2014 - is a standard protocol for any launch attempt. Excess radiation can affect the critical computer systems aboard the launch vehicle.

"The launch vehicle avionics do everything from guiding the rocket, to telling it when to start up, to moving it through the various stages, to communicating with the payload after it has been ejected," said Chris St. Cyr, a space weather scientist at NASA's Goddard Space Flight Center in Greenbelt, Md. "If there's too much radiation these crucial systems could be damaged."

There are two ways that the radiation can cause problems. First, a single well-aimed proton can interfere with the electronic systems, causing circuit damage or system shut downs. Second, a strong dose of radiation can cause degradation of microelectronics. Such radiation effects are also of concern to satellites that orbit high above Earth, and in the face of a strong proton storm spacecraft operators sometimes put their spacecraft into safe mode for added protection.

Launches, however, are simply postponed. As the radiation subsides, the Antares launch team will determine a new launch date and time.

For more on space weather effects:

http://www.nasa.gov/mission_pages/sunearth/spaceweather/index.html

For updates on the Antares launch:

http://www.nasa.gov/centers/wallops/home/index.html

Link:

Space Radiation Can Affect Rocket Launches

Seasteading: Sustainable Solution to Offshore Platforms: Urban …

(Image: Andrs Gyrfi, cc-3.0)

Seasteading the concept of creating autonomous communities at sea offers a sustainable solution to dealing with abandoned oil rigs and other redundant offshore platforms. In theory, seasteads would be established beyond the territories claimed by national governments, and some would even be mobile. As eccentric as it sounds, theres a substantial movement to make this form of oceanic dwelling a realityby 2014.

(Image: Richard Lazenby, public domain)

The term can be traced to the works of two people Ken Neumeyer and Wayne Gramlich and proposals range from refitted cruise ships and adapted oil rigs to decommissioned anti-aircraft platforms and custom-built floating islands. To date, no autonomous states exist on the high seas that are recognised as sovereign nations, although the Principality of Sealand(above) a disputed micronation located on an abandoned sea fort near the UK coast might disagree.

(Image: via JackDayton, cc-3.0)

Various other seasteading proposals have been put forward, including spar platforms and modular islands. In 2009, the Seasteading Institute patented a design for a 200-person resort called ClubStead, equivalent in size to a city block. With a focus on community, the Institute hopes to launch the first seastead in San Francisco Bay in 2014. Despite the legal issues, the concept at least presents an sustainable means of dealing with abandoned sea platforms in a community driven environment.

Keep Browsing

Partners

Here is the original post:

Seasteading: Sustainable Solution to Offshore Platforms: Urban ...

House panel votes to ban new red-light cameras

TALLAHASSEE

Installation of new red-light cameras would be banned across the state under a bill that passed a key committee in the Florida House Thursday, signaling a renewed debate over the devices use to catch traffic-light violations.

The measure, approved 10-3 by the House Transportation and Highway Safety Subcommittee, would prohibit cities and counties from installing cameras after July 1 and would sharply limit the revenue that local governments could raise from the enforcement systems.

The bill would not affect the cameras already in use by the estimated 77 local governments in Florida including Sarasota, Bradenton and Manatee County.

We are not removing the cameras that are already there, said Rep. Frank Artiles, R-Miami. What were saying is that the local governments are not going to profiteer from it. ... If its about safety, make it about safety.

Artiles said leaving the existing cameras in place would meet the safety concerns raised by camera advocates, while at the same time reducing the revenue being generated for the cities, counties and the state. Critics have called the cameras a back-door tax for local governments.

The bill is opposed by local governments and law enforcement advocates.

Our message has never changed or wavered, said Chris Connell, a Tallahassee police officer representing the Florida Police Chiefs Association. We do believe that the red-light cameras are a safety improvement and they do save lives.

Connell was not able to offer any crash statistics but said his city has seen a significant decrease in red-light violations since the cameras have been installed. That tells us driving habits have been changed, he said.

Artiles noted the safety statistics are unclear since a quarter of the local governments using the cameras do not provide any crash information to the state.

See the original post:

House panel votes to ban new red-light cameras

UFOs sighting in solar space – Browse Images NASA satellites for January 4, 2014 – Video


UFOs sighting in solar space - Browse Images NASA satellites for January 4, 2014
Giant cube - UFO hologram 0:54 Please help me make my channel better! Visit the main page of the channel. http://www.youtube.com/myunhauzen74 And click on th...

By: myunhauzen74

The rest is here:

UFOs sighting in solar space - Browse Images NASA satellites for January 4, 2014 - Video